The open index of psychedelic research

An auxiliary protein tunes reductase activity in alkaloid biosynthesis

Carr SC, Wu S, Gase K +8

Interpretive Reference Ranges for Plasma Drug Concentrations in Acute Recreational Drug Toxicity: A Short Communication.

Boccuzzi S, Battal D, Cowan D +2

Toxicokinetic Studies of the Two Stimulants M-ALPHA and <i>N</i>-Methyl-cyclazodone Using In Vitro and In Vivo Tools.

Gampfer TM, Klaes S, Eckstein N +1

Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects

Hinchcliffe JK, Bartlett J, Thomas CW +4

Evidence in practice: implementing KAT in indigenous health services.

Lovely JJ, Yardley H, Darda R +6

Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.

Baral A, Pan Y, Hlaing WM +3

Prevalence and Correlates of Past-Year Psilocybin Use in the United States.

Yang KH, Eun A, Palamar JJ

Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice

Knox CA, Woodburn SC, Gilbert AD +2

Wherefore the Magic? The Evolutionary Role of Psilocybin in Nature.

Matthews Nicholass KJ, Flis I, Hanley ME +14

A 25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.

Feldman R, Audette M, Leacock PR +1

Restoring oscillatory dynamics in Alzheimer's disease: A laminar whole-brain model of serotonergic psychedelic effects.

Gendra JC, Lopez-Sola E, Castaldo F +6

Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition time.

Sheheitli H, Hermosillo R, Grimsrud G +5

Autonomic indicators of self-transcendence: insights from the numadelic VR paradigm.

Bonnelle V, Parola G, Andreu C +6

Esketamine-sufentanil PCA reduces postoperative depression state in elderly colorectal cancer patients: a randomized controlled trial.

Ding R, Wang D, Wang G +6

Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression.

Coggins NC, Chokr HA, Meyer TA +3

Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins.

Drange S, Cohen J, Johansen SS +2

Serotonergic Polypharmacology of 2-Halogenated Tryptamines

Yacoub J, Bray E, Bayyat J +14

Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms.

Bredenberg C, Normandin F, Richards B +1

Pharmacological sedation strategies for therapeutic gastrointestinal endoscopy: a systematic review and network meta-analysis of randomised controlled trials.

Jiang H, Xie Y, Qin X +4

From legalisation to practice: implementation of newly legalised health interventions in healthcare settings - a systematic review.

Vizheh M, Lamprell K, Sheriff S +5

<i>R</i>-MDDMA is a Safer Analogue of MDMA with Therapeutic Potential.

Vargas MV, Hatzipantelis CJ, Dunlap LE +7

Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.

Abramsky-Sze S, Marseille E, Matzopoulos R +2

Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain Connectivity

Bhagavan C, Dandash O, Carter O +2

Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery